By proceeding, you agree to our Terms of Use and Privacy Policy.
Singzyme's mission is to deliver on the promise of effective immuno-therapies by developing safer and more homogenous, precision medicines for the well-being of patients worldwide. Singzyme applies its platform technology in the field of immuno-therapies with a focus on the conjugation of active molecules to protein carriers, for example, but not limited to Antibody-Drug Conjugates (ADCs). Singzyme provides an integrated, high-speed, precision bio-manufacturing platform for ADCs and other bioconjugates.
22-24 August 2023
The ADC Linker & Conjugation Summit is a significant event for those involved in developing ADC drugs. With the increasing use of site-specific ADCs, the development of new conjugation technologies and linker chemistry, as well as the expansion of th
Event Ended
USA
Paid
Boston
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea
San Diego